Noramco™
Jan Wood is a highly experienced professional in the pharmaceutical industry, with a career spanning over two decades. Jan has held various quality assurance and managerial roles at reputable companies such as Noramco™, Centocor (J&J Company), and SmithKline Beecham (currently Glaxo SmithKline). Jan's expertise lies in areas such as tech transfer, product release, supplier audits, DEA and FDA compliance, and annual product reports. Jan holds a Master's degree in Global Management from the University of Phoenix and a Bachelor of Science in Food Science from Michigan State University. Jan's extensive experience and dedication to quality assurance make their a valuable asset in the pharmaceutical industry.
Noramco™
Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III